West Nile virus cases in Greece jump in 2018
ATHENS (Reuters) – Eleven people have died and 107 infected by the mosquito-borne West Nile virus in Greece so far this summer, authorities said, the highest number of reported cases…
Doctor in eastern Congo contracts Ebola in ‘dreaded’ scenario: WHO
GENEVA (Reuters) – A doctor has become the first probable Ebola case in one of the eastern Democratic Republic of Congo’s most violence-ridden and inaccessible zones, a scenario “we have…
Exclusive: Pharma sector warns Saudis on German drug curbs
BERLIN (Reuters) – European and U.S. pharmaceutical associations have waded into a diplomatic row between Germany and Saudi Arabia, warning that ongoing restrictions on German-made drugs could hurt Saudi patients…
U.S. health secretary says agency can eliminate drug rebates
WASHINGTON (Reuters) – U.S. Health and Human Services Secretary Alex Azar said it was within his agency’s power to eliminate rebates on prescription drug purchases, a key element of the…
Militia threat hampers Ebola fight in Congo as disease kills 47
GENEVA (Reuters) – Militia violence in Democratic Republic of Congo has prevented aid workers from reaching some potential cases in an outbreak of Ebola that has so far killed 47…
China sacks six senior officials at food and drug regulator over vaccine scandal
SHANGHAI (Reuters) – China said on Saturday it has sacked six senior officials at its food and drug regulator after a safety scandal at vaccine maker Changsheng Biotechnology Co Ltd…
Pfizer bets on biotech flu vaccine in $425 million BioNTech alliance
FRANKFURT (Reuters) – Pfizer has agreed to pay German biotech firm BioNTech up to $425 million in an alliance to develop more effective influenza jabs, the latest among several major…
China finds second African swine fever case at WH Group plant
BEIJING (Reuters) – China found its second case of African swine fever (ASF) on Thursday at a slaughterhouse owned by WH Group Ltd’s Chinese unit, stirring concerns about the spread…
Long-acting injection a shot in the arm for GSK’s HIV business
LONDON (Reuters) – A long-acting injection developed by GlaxoSmithKline (GSK.L) and given once a month has proved as effective as standard daily pills for controlling the AIDS virus, lifting prospects…
Biogen’s pricey muscle drug Spinraza too costly for Britain
LONDON (Reuters) – Biogen’s muscle disease treatment Spinraza has been deemed too expensive for use on Britain’s state-run health service, even after a price discount offered by the U.S. drugmaker.…